I mean perhaps all this Indian indolence would be palatable if the company had something going in terms of sales. However, they've stated previously they don't want to make too much revenue because it will ruin their ability to get R and D grants. It's like a bludger not getting a job because his centrelink will dry up.
- Forums
- ASX - By Stock
- Latest NLC Annual Report 2017-2018
I mean perhaps all this Indian indolence would be palatable if...
-
- There are more pages in this discussion • 18 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add ECT (ASX) to my watchlist
|
|||||
Last
0.3¢ |
Change
-0.001(14.3%) |
Mkt cap ! $9.515M |
Open | High | Low | Value | Volume |
0.3¢ | 0.3¢ | 0.3¢ | $2.551K | 850.2K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
40 | 17863034 | 0.3¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
0.4¢ | 11678961 | 27 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
40 | 17863034 | 0.003 |
19 | 13382678 | 0.002 |
10 | 17300024 | 0.001 |
0 | 0 | 0.000 |
0 | 0 | 0.000 |
Price($) | Vol. | No. |
---|---|---|
0.004 | 11678961 | 27 |
0.005 | 5451603 | 27 |
0.006 | 5239567 | 10 |
0.007 | 1118334 | 6 |
0.008 | 332213 | 4 |
Last trade - 13.11pm 03/07/2024 (20 minute delay) ? |
Featured News
ECT (ASX) Chart |
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham, CEO
James Graham
CEO
Previous Video
Next Video
SPONSORED BY The Market Online